SLS
Sellas Life Sciences Group Inc
11.50$
-0.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 260.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.49 | 0.05 | 0.00 | 0.00 | 0.00 | |
| 39.18 | 17.75 | 0.01 | 0.00 | 0.00 | – | 0.05 | 0.01 | 0.01 | 0.00 | – | – | |
| 221.05 | -17.75 | -0.01 | 0.00 | 0.00 | – | 0.00 | 0.48 | 0.05 | 0.00 | – | – | |
| 791.77 | 1,180.55 | 59.83 | 129.62 | 70.03 | 3.95 | 1.16 | 1.38 | 1.56 | 0.86 | 0.31 | 0.15 | |
| 875.26 | 530.45 | 36.17 | 322.37 | 48.83 | 3.88 | 1.20 | 0.73 | 0.65 | 0.50 | 0.20 | 0.11 | |
| 1,679.32 | 1,693.25 | 96.00 | 451.98 | 120.78 | 7.83 | -2.37 | 2.11 | 2.21 | 1.36 | 0.51 | 0.26 | |
| -1,022.20 | -1,711.00 | -48.16 | -335.72 | -120.78 | -7.83 | -2.13 | -1.63 | -2.16 | -1.36 | -0.51 | -0.26 | |
| 31.00 | 38.00 | 10.57 | 9.87 | 1.02 | 0.05 | 0.05 | 0.28 | 0.03 | – | – | – | |
| -1,022.20 | -1,929.55 | -53.26 | -502.08 | -111.06 | -7.57 | -2.10 | -1.35 | -2.13 | -1.34 | -0.50 | -0.25 | |
| -431.32 | 18.25 | 0.73 | 5.41 | -5.27 | -0.03 | 0.00 | -0.02 | -0.03 | -1.36 | – | – | |
| -1,022.20 | -3,195.10 | -70.94 | -507.49 | -105.80 | -7.54 | -2.10 | -1.34 | -2.13 | -1.34 | -0.50 | -0.25 | |
| -1,022.20 | -1,873.80 | -48.15 | -492.21 | -127.69 | 0.26 | 3.33 | -1.18 | -1.62 | 0.02 | 0.01 | -0.25 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.